Larotrectinib (LOXO-101) is an orally administered inhibitor of the TRK kinase, demonstrating high selectivity exclusively for the TRK family of receptors (IC50s = 2-20 nM).
Molecular Weight:
428.44
Purity:
99.15%
CAS Number:
[1223403-58-4]
Formula:
C21H22F2N6O2
Target:
Trk receptor|||Apoptosis
T5995
* VAT and and shipping costs not included. Errors and price changes excepted